Donor safety in living donor liver donation: An Italian multicenter survey

Andrea Lauterio, Stefano Di Sandro, Salvatore Gruttadauria, Marco Spada, Fabrizio Di Benedetto, Umberto Baccarani, Enrico Regalia, Ernesto Melada, Alessandro Giacomoni, Matteo Cescon, Davide Cintorino, Giorgio Ercolani, Matteo Rota, Giorgio Rossi, Vincenzo Mazzaferro, Andrea Risaliti, Antonio Daniele Pinna, Bruno Gridelli, Luciano De Carlis

Research output: Contribution to journalArticle

Abstract

Major concerns about donor morbidity and mortality still limit the use of living donor liver transplantation (LDLT) to overcome the organ shortage. The present study assessed donor safety in LDLT in Italy reporting donor postoperative outcomes in 246 living donation procedures performed by 7 transplant centers. Outcomes were evaluated over 2 time periods using the validated Clavien 5-tier grading system, and several clinical variables were analyzed to determine the risk factors for donor morbidity. Different grafts were obtained from the 246 donor procedures (220 right lobe, 10 left lobe, and 16 left lateral segments). The median follow-up after donation was 112 months. There was no donor mortality. One or more complications occurred in 82 (33.3%) donors, and 3 of them had intraoperative complications (1.2%). Regardless of graft type, the rate of major complications (grade ≥ 3) was 12.6% (31/246). The overall donor morbidity and the rate of major complications did not differ significantly over time: 26 (10.6%) donors required hospital readmission throughout the follow-up period, whereas 5 (2.0%) donors required reoperation. Prolonged operative time (>400 minutes), intraoperative hypotension (systolic < 100 mm Hg), vascular abnormalities, and intraoperative blood loss (>300 mL) were multivariate risk factors for postoperative donor complications. In conclusion, from the standpoint of living donor surgery, a meticulous and well-standardized technique that reduces operative time and prevents blood loss and intraoperative hypotension may reduce the incidence of donor complications. Transparency in reporting results after LDLT is mandatory, and we should continue to strive for zero donor mortality. Liver Transplantation 23 184-193 2017 AASLD.

Original languageEnglish
Pages (from-to)184-193
Number of pages10
JournalLiver Transplantation
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 2017

Fingerprint

Living Donors
Tissue Donors
Safety
Liver
Liver Transplantation
Operative Time
Morbidity
Transplants
Surveys and Questionnaires
Hypotension
Mortality
Patient Readmission
Intraoperative Complications
Reoperation
Italy

Keywords

  • Adolescent
  • Adult
  • Blood Loss, Surgical
  • Female
  • Follow-Up Studies
  • Hepatectomy
  • Humans
  • Hypotension
  • Incidence
  • Intraoperative Complications
  • Italy
  • Liver Transplantation
  • Living Donors
  • Male
  • Middle Aged
  • Operative Time
  • Patient Readmission
  • Postoperative Complications
  • Reoperation
  • Risk Factors
  • Surveys and Questionnaires
  • Young Adult
  • Journal Article
  • Multicenter Study

Cite this

Lauterio, A., Di Sandro, S., Gruttadauria, S., Spada, M., Di Benedetto, F., Baccarani, U., ... De Carlis, L. (2017). Donor safety in living donor liver donation: An Italian multicenter survey. Liver Transplantation, 23(2), 184-193. https://doi.org/10.1002/lt.24651

Donor safety in living donor liver donation : An Italian multicenter survey. / Lauterio, Andrea; Di Sandro, Stefano; Gruttadauria, Salvatore; Spada, Marco; Di Benedetto, Fabrizio; Baccarani, Umberto; Regalia, Enrico; Melada, Ernesto; Giacomoni, Alessandro; Cescon, Matteo; Cintorino, Davide; Ercolani, Giorgio; Rota, Matteo; Rossi, Giorgio; Mazzaferro, Vincenzo; Risaliti, Andrea; Pinna, Antonio Daniele; Gridelli, Bruno; De Carlis, Luciano.

In: Liver Transplantation, Vol. 23, No. 2, 02.2017, p. 184-193.

Research output: Contribution to journalArticle

Lauterio, A, Di Sandro, S, Gruttadauria, S, Spada, M, Di Benedetto, F, Baccarani, U, Regalia, E, Melada, E, Giacomoni, A, Cescon, M, Cintorino, D, Ercolani, G, Rota, M, Rossi, G, Mazzaferro, V, Risaliti, A, Pinna, AD, Gridelli, B & De Carlis, L 2017, 'Donor safety in living donor liver donation: An Italian multicenter survey', Liver Transplantation, vol. 23, no. 2, pp. 184-193. https://doi.org/10.1002/lt.24651
Lauterio A, Di Sandro S, Gruttadauria S, Spada M, Di Benedetto F, Baccarani U et al. Donor safety in living donor liver donation: An Italian multicenter survey. Liver Transplantation. 2017 Feb;23(2):184-193. https://doi.org/10.1002/lt.24651
Lauterio, Andrea ; Di Sandro, Stefano ; Gruttadauria, Salvatore ; Spada, Marco ; Di Benedetto, Fabrizio ; Baccarani, Umberto ; Regalia, Enrico ; Melada, Ernesto ; Giacomoni, Alessandro ; Cescon, Matteo ; Cintorino, Davide ; Ercolani, Giorgio ; Rota, Matteo ; Rossi, Giorgio ; Mazzaferro, Vincenzo ; Risaliti, Andrea ; Pinna, Antonio Daniele ; Gridelli, Bruno ; De Carlis, Luciano. / Donor safety in living donor liver donation : An Italian multicenter survey. In: Liver Transplantation. 2017 ; Vol. 23, No. 2. pp. 184-193.
@article{c6c9ef83004b4fbda6636c80d2fc1ef3,
title = "Donor safety in living donor liver donation: An Italian multicenter survey",
abstract = "Major concerns about donor morbidity and mortality still limit the use of living donor liver transplantation (LDLT) to overcome the organ shortage. The present study assessed donor safety in LDLT in Italy reporting donor postoperative outcomes in 246 living donation procedures performed by 7 transplant centers. Outcomes were evaluated over 2 time periods using the validated Clavien 5-tier grading system, and several clinical variables were analyzed to determine the risk factors for donor morbidity. Different grafts were obtained from the 246 donor procedures (220 right lobe, 10 left lobe, and 16 left lateral segments). The median follow-up after donation was 112 months. There was no donor mortality. One or more complications occurred in 82 (33.3{\%}) donors, and 3 of them had intraoperative complications (1.2{\%}). Regardless of graft type, the rate of major complications (grade ≥ 3) was 12.6{\%} (31/246). The overall donor morbidity and the rate of major complications did not differ significantly over time: 26 (10.6{\%}) donors required hospital readmission throughout the follow-up period, whereas 5 (2.0{\%}) donors required reoperation. Prolonged operative time (>400 minutes), intraoperative hypotension (systolic < 100 mm Hg), vascular abnormalities, and intraoperative blood loss (>300 mL) were multivariate risk factors for postoperative donor complications. In conclusion, from the standpoint of living donor surgery, a meticulous and well-standardized technique that reduces operative time and prevents blood loss and intraoperative hypotension may reduce the incidence of donor complications. Transparency in reporting results after LDLT is mandatory, and we should continue to strive for zero donor mortality. Liver Transplantation 23 184-193 2017 AASLD.",
keywords = "Adolescent, Adult, Blood Loss, Surgical, Female, Follow-Up Studies, Hepatectomy, Humans, Hypotension, Incidence, Intraoperative Complications, Italy, Liver Transplantation, Living Donors, Male, Middle Aged, Operative Time, Patient Readmission, Postoperative Complications, Reoperation, Risk Factors, Surveys and Questionnaires, Young Adult, Journal Article, Multicenter Study",
author = "Andrea Lauterio and {Di Sandro}, Stefano and Salvatore Gruttadauria and Marco Spada and {Di Benedetto}, Fabrizio and Umberto Baccarani and Enrico Regalia and Ernesto Melada and Alessandro Giacomoni and Matteo Cescon and Davide Cintorino and Giorgio Ercolani and Matteo Rota and Giorgio Rossi and Vincenzo Mazzaferro and Andrea Risaliti and Pinna, {Antonio Daniele} and Bruno Gridelli and {De Carlis}, Luciano",
note = "{\circledC} 2016 by the American Association for the Study of Liver Diseases.",
year = "2017",
month = "2",
doi = "10.1002/lt.24651",
language = "English",
volume = "23",
pages = "184--193",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Donor safety in living donor liver donation

T2 - An Italian multicenter survey

AU - Lauterio, Andrea

AU - Di Sandro, Stefano

AU - Gruttadauria, Salvatore

AU - Spada, Marco

AU - Di Benedetto, Fabrizio

AU - Baccarani, Umberto

AU - Regalia, Enrico

AU - Melada, Ernesto

AU - Giacomoni, Alessandro

AU - Cescon, Matteo

AU - Cintorino, Davide

AU - Ercolani, Giorgio

AU - Rota, Matteo

AU - Rossi, Giorgio

AU - Mazzaferro, Vincenzo

AU - Risaliti, Andrea

AU - Pinna, Antonio Daniele

AU - Gridelli, Bruno

AU - De Carlis, Luciano

N1 - © 2016 by the American Association for the Study of Liver Diseases.

PY - 2017/2

Y1 - 2017/2

N2 - Major concerns about donor morbidity and mortality still limit the use of living donor liver transplantation (LDLT) to overcome the organ shortage. The present study assessed donor safety in LDLT in Italy reporting donor postoperative outcomes in 246 living donation procedures performed by 7 transplant centers. Outcomes were evaluated over 2 time periods using the validated Clavien 5-tier grading system, and several clinical variables were analyzed to determine the risk factors for donor morbidity. Different grafts were obtained from the 246 donor procedures (220 right lobe, 10 left lobe, and 16 left lateral segments). The median follow-up after donation was 112 months. There was no donor mortality. One or more complications occurred in 82 (33.3%) donors, and 3 of them had intraoperative complications (1.2%). Regardless of graft type, the rate of major complications (grade ≥ 3) was 12.6% (31/246). The overall donor morbidity and the rate of major complications did not differ significantly over time: 26 (10.6%) donors required hospital readmission throughout the follow-up period, whereas 5 (2.0%) donors required reoperation. Prolonged operative time (>400 minutes), intraoperative hypotension (systolic < 100 mm Hg), vascular abnormalities, and intraoperative blood loss (>300 mL) were multivariate risk factors for postoperative donor complications. In conclusion, from the standpoint of living donor surgery, a meticulous and well-standardized technique that reduces operative time and prevents blood loss and intraoperative hypotension may reduce the incidence of donor complications. Transparency in reporting results after LDLT is mandatory, and we should continue to strive for zero donor mortality. Liver Transplantation 23 184-193 2017 AASLD.

AB - Major concerns about donor morbidity and mortality still limit the use of living donor liver transplantation (LDLT) to overcome the organ shortage. The present study assessed donor safety in LDLT in Italy reporting donor postoperative outcomes in 246 living donation procedures performed by 7 transplant centers. Outcomes were evaluated over 2 time periods using the validated Clavien 5-tier grading system, and several clinical variables were analyzed to determine the risk factors for donor morbidity. Different grafts were obtained from the 246 donor procedures (220 right lobe, 10 left lobe, and 16 left lateral segments). The median follow-up after donation was 112 months. There was no donor mortality. One or more complications occurred in 82 (33.3%) donors, and 3 of them had intraoperative complications (1.2%). Regardless of graft type, the rate of major complications (grade ≥ 3) was 12.6% (31/246). The overall donor morbidity and the rate of major complications did not differ significantly over time: 26 (10.6%) donors required hospital readmission throughout the follow-up period, whereas 5 (2.0%) donors required reoperation. Prolonged operative time (>400 minutes), intraoperative hypotension (systolic < 100 mm Hg), vascular abnormalities, and intraoperative blood loss (>300 mL) were multivariate risk factors for postoperative donor complications. In conclusion, from the standpoint of living donor surgery, a meticulous and well-standardized technique that reduces operative time and prevents blood loss and intraoperative hypotension may reduce the incidence of donor complications. Transparency in reporting results after LDLT is mandatory, and we should continue to strive for zero donor mortality. Liver Transplantation 23 184-193 2017 AASLD.

KW - Adolescent

KW - Adult

KW - Blood Loss, Surgical

KW - Female

KW - Follow-Up Studies

KW - Hepatectomy

KW - Humans

KW - Hypotension

KW - Incidence

KW - Intraoperative Complications

KW - Italy

KW - Liver Transplantation

KW - Living Donors

KW - Male

KW - Middle Aged

KW - Operative Time

KW - Patient Readmission

KW - Postoperative Complications

KW - Reoperation

KW - Risk Factors

KW - Surveys and Questionnaires

KW - Young Adult

KW - Journal Article

KW - Multicenter Study

U2 - 10.1002/lt.24651

DO - 10.1002/lt.24651

M3 - Article

C2 - 27712040

VL - 23

SP - 184

EP - 193

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 2

ER -